![Peptide](/media/m52mdufw/peptide.png?rxy=0.5003966277418046,0.6593801826283294&width=960&height=725&format=webp&quality=80&rnd=133172390930970000;)
Peptide Therapeutics
Although low molecular weight means less complexity, peptide-based therapeutics are by no means a product that's easy to develop.
Overcoming an inherently low stability, which contributes to rapid degradation and clearance in-vivo, and being in control of self-aggregation demands for characterization techniques that reliably monitor structural integrity. CD spectroscopy is well-suited for this purpose, and Chirascan systems provide the required sensitivity.